Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost Formulation B vs Lumigan in Glaucoma/Ocular Hypertension
NCT01099774Phase 3Completed
- Sponsor
- Allergan
- Start
- May 2010
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bimatoprost in Glaucoma, ocular hypertension, sponsored by Allergan. Started May 2010; status: completed.
02
Drugs
bimatoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT01099774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01099774.